Biomaterials legislation passes hurdle in US
This article was originally published in Clinica
Executive Summary
The US House Commerce Committee unanimously passed the Biomaterials Access Assurance Act of 1997 on June 24. The legislation is designed to protect biomaterials manufacturers from financially damaging product liability lawsuits and address the shortage of biomaterials medical device manufacturers are facing (see Clinica No 813, p 3).